Howard Colman

44.1k total citations · 8 hit papers
151 papers, 11.8k citations indexed

About

Howard Colman is a scholar working on Genetics, Oncology and Cancer Research. According to data from OpenAlex, Howard Colman has authored 151 papers receiving a total of 11.8k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Genetics, 54 papers in Oncology and 52 papers in Cancer Research. Recurrent topics in Howard Colman's work include Glioma Diagnosis and Treatment (103 papers), Brain Metastases and Treatment (21 papers) and Cancer Genomics and Diagnostics (21 papers). Howard Colman is often cited by papers focused on Glioma Diagnosis and Treatment (103 papers), Brain Metastases and Treatment (21 papers) and Cancer Genomics and Diagnostics (21 papers). Howard Colman collaborates with scholars based in United States, Canada and Switzerland. Howard Colman's co-authors include Adam L. Cohen, Kenneth Aldape, Burt G. Feuerstein, Anjan Misra, Janice Nigro, Erik P. Sulman, Ken Aldape, Heidi Phillips, Robert Soriano and Liliana Soroceanu and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Howard Colman

143 papers receiving 11.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis

2006 2.3k citations Anjan Misra, Janice Nigro et al. profile →
The transcriptional network for mesenchymal transformation of brain tumours

2009 919 citations Erik P. Sulman, Howard Colman et al. profile →
cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”

2018 553 citations Kenneth Aldape, Howard Colman et al. profile →
Glioma Subclassifications and Their Clinical Significance

2017 544 citations Adam L. Cohen, Howard Colman et al. profile →
FoxM1 Promotes β-Catenin Nuclear Localization and Controls Wnt Target-Gene Expression and Glioma Tumorigenesis

2011 473 citations Howard Colman, W.K. Alfred Yung et al. profile →
IDH1 and IDH2 Mutations in Gliomas

2013 451 citations Adam L. Cohen, Sheri L. Holmen et al. profile →
Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study

2015 433 citations Howard Colman, John de Groot et al. profile →
cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas

2020 310 citations Kenneth Aldape, Howard Colman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Howard Colman United States	46	6.1k	5.8k	3.8k	2.9k	1.8k	151	11.8k
Hai Yan United States	37	5.5k 0.9×	7.1k 1.2×	4.6k 1.2×	2.2k 0.8×	2.0k 1.1×	91	12.5k
Jason T. Huse United States	50	4.8k 0.8×	6.2k 1.1×	3.6k 1.0×	2.9k 1.0×	1.3k 0.8×	131	12.3k
Christel Herold‐Mende Germany	63	5.6k 0.9×	6.3k 1.1×	3.6k 1.0×	4.3k 1.5×	1.7k 1.0×	313	14.4k
Peter Hau Germany	43	6.9k 1.1×	5.1k 0.9×	3.2k 0.8×	2.8k 1.0×	2.2k 1.2×	189	11.9k
Linda M. Liau United States	54	5.8k 0.9×	6.0k 1.0×	4.0k 1.0×	3.2k 1.1×	1.6k 0.9×	221	13.7k
D. Williams Parsons United States	31	4.7k 0.8×	5.3k 0.9×	3.3k 0.9×	1.9k 0.7×	1.3k 0.7×	92	10.2k
Erik P. Sulman United States	52	3.7k 0.6×	5.2k 0.9×	3.1k 0.8×	2.4k 0.9×	2.1k 1.2×	223	10.5k
W.K. Alfred Yung United States	64	6.4k 1.1×	8.1k 1.4×	3.2k 0.8×	3.8k 1.3×	2.9k 1.7×	175	15.0k
Marie‐France Hamou Switzerland	31	5.3k 0.9×	4.1k 0.7×	2.7k 0.7×	1.8k 0.6×	1.8k 1.0×	46	9.0k
Rolf Bjerkvig Norway	59	3.8k 0.6×	6.3k 1.1×	3.3k 0.9×	3.4k 1.2×	956 0.5×	235	12.7k

Countries citing papers authored by Howard Colman

Since Specialization

Citations

This map shows the geographic impact of Howard Colman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard Colman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard Colman more than expected).

Fields of papers citing papers by Howard Colman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Howard Colman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard Colman. The network helps show where Howard Colman may publish in the future.

Co-authorship network of co-authors of Howard Colman

This figure shows the co-authorship network connecting the top 25 collaborators of Howard Colman. A scholar is included among the top collaborators of Howard Colman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Howard Colman. Howard Colman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kircher, David A., et al.. (2025). Combined inhibition of focal adhesion kinase and RAF/MEK elicits synergistic inhibition of melanoma growth and reduces metastases. Cell Reports Medicine. 6(2). 101943–101943. 2 indexed citations

Groot, John Frederick De, Timothy F. Cloughesy, Donald A. Berry, et al.. (2024). Evaluation of VAL-083 in GBM AGILE, a phase 3 registration platform trial for newly diagnosed and recurrent glioblastoma.. Journal of Clinical Oncology. 42(16_suppl). 2005–2005.

Underhill, Hunter R., Michael Karsy, Christian J. Davidson, et al.. (2024). Subclonal Cancer Driver Mutations Are Prevalent in the Unresected Peritumoral Edema of Adult Diffuse Gliomas. Cancer Research. 84(7). 1149–1164. 4 indexed citations

Boucher, Kenneth M., Dennis C. Shrieve, Gita Suneja, et al.. (2024). D-TERMINED, a phase 1 trial in newly diagnosed high-grade glioma with temozolomide, radiation, and minocycline followed by adjuvant minocycline/temozolomide. Neuro-Oncology Advances. 6(1). vdae063–vdae063. 1 indexed citations

Ose, Dominik, et al.. (2024). The association of diabetes mellitus and routinely collected patient‐reported outcomes in patients with cancer. A real‐world cohort study. Cancer Medicine. 13(20). e70246–e70246. 1 indexed citations

Chow, Frances, David W. Craig, D. Ryan Ormond, et al.. (2024). Profiling the molecular and clinical landscape of glioblastoma utilizing the Oncology Research Information Exchange Network brain cancer database. Neuro-Oncology Advances. 6(1). vdae046–vdae046. 3 indexed citations

Chen, James L., Aakrosh Ratan, Martin D. McCarter, et al.. (2023). The T Cell Immunoscore as a Reference for Biomarker Development Utilizing Real-World Data from Patients with Advanced Malignancies Treated with Immune Checkpoint Inhibitors. Cancers. 15(20). 4913–4913. 5 indexed citations

Wang, Xuefeng, Vineeth Sukrithan, Aakrosh Ratan, et al.. (2023). Incorporating long non-coding RNA (lncRNA) into genome-wide biomarker screening for prognostic gene signatures of immunotherapy outcomes.. Journal of Clinical Oncology. 41(16_suppl). 2617–2617. 2 indexed citations

Holowatyj, Andreana N., Richard Viskochil, Dominik Ose, et al.. (2020). Diabetes, Body Fatness, and Insulin Prescription Among Adolescents and Young Adults with Cancer. Journal of Adolescent and Young Adult Oncology. 10(2). 217–225. 10 indexed citations

10.

Reblin, Maija, Yelena P. Wu, Howard Colman, et al.. (2017). Development of the Electronic Social Network Assessment Program Using the Center for eHealth and Wellbeing Research Roadmap. JMIR Human Factors. 4(3). e23–e23. 23 indexed citations

11.

Ravindra, Vijay M., Adam L. Cohen, Randy L. Jensen, et al.. (2015). Molecular features assisting in diagnosis, surgery, and treatment decision making in low-grade gliomas. Neurosurgical FOCUS. 38(3). E2–E2. 40 indexed citations

12.

Karsy, Michael, Jayson A. Neil, Jian Guan, et al.. (2015). A practical review of prognostic correlations of molecular biomarkers in glioblastoma. Neurosurgical FOCUS. 38(3). E4–E4. 88 indexed citations

13.

Karsy, Michael, Jian Guan, Randy L. Jensen, Eric Huang, & Howard Colman. (2015). The Impact of Hypoxia and Mesenchymal Transition on Glioblastoma Pathogenesis and Cancer Stem Cells Regulation. World Neurosurgery. 88. 222–236. 18 indexed citations

14.

Cohen, Adam L., Mariko Sato, Kenneth Aldape, et al.. (2015). DNA copy number analysis of Grade II–III and Grade IV gliomas reveals differences in molecular ontogeny including chromothripsis associated with IDH mutation status. Acta Neuropathologica Communications. 3(1). 34–34. 63 indexed citations

15.

Giglio, Pierre, Kenneth R. Hess, Mark R. Gilbert, et al.. (2011). Phase 2 trial of irinotecan and thalidomide in adults with recurrent anaplastic glioma. Cancer. 118(14). 3599–3606. 12 indexed citations

16.

Galanis, Evanthia, Wenting Wu, Jann N. Sarkaria, et al.. (2010). Incorporation of Biomarker Assessment in Novel Clinical Trial Designs: Personalizing Brain Tumor Treatments. Current Oncology Reports. 13(1). 42–49. 18 indexed citations

17.

Pelloski, Christopher E., Karla V. Ballman, Alfred Furth, et al.. (2007). Epidermal Growth Factor Receptor Variant III Status Defines Clinically Distinct Subtypes of Glioblastoma. Journal of Clinical Oncology. 25(16). 2288–2294. 239 indexed citations

18.

Sulman, Erik P., Christopher E. Pelloski, J. Matthew McDonald, et al.. (2007). Podoplanin expression is an independent predictor of survival in malignant gliomas. Cancer Research. 67. 2438–2438. 1 indexed citations

19.

Colman, Howard, Brian Berkey, Moshe Maor, et al.. (2006). Phase II Radiation Therapy Oncology Group trial of conventional radiation therapy followed by treatment with recombinant interferon-β for supratentorial glioblastoma: Results of RTOG 9710. International Journal of Radiation Oncology*Biology*Physics. 66(3). 818–824. 45 indexed citations

20.

Nigro, Janice, Anjan Misra, Li Zhang, et al.. (2005). Integrated Array-Comparative Genomic Hybridization and Expression Array Profiles Identify Clinically Relevant Molecular Subtypes of Glioblastoma. Cancer Research. 65(5). 1678–1686. 261 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact